Increased access to medical methods of abortion could significantly reduce
maternal mortality, especially in developing countries. In Light of the pol
itical and commercial difficulties in distributing the abortifacient mifepr
istone, the widely studied mifepristone-misoprostol regimen may not be suff
iciently available in the near future. Thus, researchers have begun to look
for alternative regimens, including regimens using misoprostol alone. This
article reviews the current available evidence on the potential of a misop
rostol-alone regimen for medical abortion. Although the data are varied and
difficult to compare, recent studies indicate that a misoprostol-alone reg
imen could be safe and effective as a method of medical abortion. Misoprost
ol is widely marketed around the world for its other indications and is ine
xpensive, stable in tropical climates, easy to transport, and simple to adm
inister. A misoprostol-alone regimen of medical abortion could thus greatly
improve the access to safe medical abortion services by women in developin
g countries. CONTRACEPTION 1999;59:209-217 (C) 1999 Elsevier Science Inc. A
ll rights reserved.